News Feed Opinion Blog Posts Career Updates Insight Dialogues Celebrities Oncolibrary
Positive Societies Drugs Stories History Cancer Center Near Me Cancer Types Immune Oncology Oncologist Near Me
August, 2025
August 2025
M T W T F S S
 123
45678910
11121314151617
18192021222324
25262728293031
Yüksel Ürün: Important information for lung cancer patients taking TKIs
Photo from Yüksel Ürün/X
Mar 9, 2024, 12:51

Yüksel Ürün: Important information for lung cancer patients taking TKIs

Yüksel Ürün, Professor of medicine in the Department of Medical Oncology of Ankara University School of Medicine, Turkey, shared a post on X:

“Important information for lung cancer patients taking TKIs (tyrosine kinase inhibitor)

Lung cancer patients taking both PPIs (proton pump inhibitor) and certain TKIs may have higher risk of death!
New study finds drug drug interaction reduces drug effectiveness.
Avoid unnecessary drug use!”

Yüksel Ürün: Important information for lung cancer patients taking TKIs

Read further.
Source: Yüksel Ürün/X

cancer Lung cancer OncoDaily Oncology Research Tyrosine Kinase Inhibitor (TKI) Yüksel Ürün
Special Coverage
Voices
Aug 25, 2025, 20:33
Alfonso Fiorelli: Surgery for Advanced Stage Lung Cancer
Voices
Aug 25, 2025, 20:13
Ahmed Warrad: A Transformative Journey in Pediatric Oncology at Burjeel Medical City
Voices
Aug 25, 2025, 19:54
Daniel Kelly Highlighted Peter Sasieni’s Take on HPV and Cancer Prevention
Voices
Aug 25, 2025, 19:00
Jarushka Naidoo: Irish Oncology in Full Force at the ESMO Academy 2025
Voices
Aug 25, 2025, 18:30
Shadha S. Al-Raisi: The Latest Cancer Incidence Report in Oman Has Been Released
Insight
Aug 25, 2025, 17:47
Alexey Kulikov: Key Findings from the Recent Meta-Analysis on Daily Steps and Health Outcomes
Voices
Aug 25, 2025, 17:36
Lauren Kriger Groner: Learning to Make White Ribbons from the Very Best
Science
Aug 25, 2025, 17:28
Galip Can Uyar: How GA-Guided Care Improves Coping in Older Adults with Metastatic Cancer
Science
Aug 25, 2025, 17:18
Giuseppe Banna: Deferred Nephrectomy after ICI in RCC May Enable Treatment De-Escalation
Science
Aug 25, 2025, 17:08
Moazzam Shahzad: Upfront Immunotherapy Approaches in the Management of Adults with ALL
Science
Aug 25, 2025, 17:00
Chris Poulios: Pathologist-Read vs AI-Driven Assessment of Tumor-Infiltrating Lymphocytes in Melanoma
Voices
Aug 25, 2025, 16:44
Martin Zapata Laguado: Honored to Speak on mRCC First-Line Therapy and dCN in the IO Era